April 06, 2017
Four independent pharmacies filed a proposed class action against Teva Pharmaceuticals, Heritage Pharmaceuticals and other drugmakers in Pennsylvania federal court on Wednesday, claiming the companies conspired to jack up the price of a generic diabetes medication to "astounding" levels.